Found 62 matching trials
Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin PHASE4 The goal of the study is to demonstrate whether a switch from insulin thera...
Show More Learn More & Join Trial
Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM NA A multi-year clinical study to improve tools for measuring the function of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg PHASE1 A randomized, open-label, multiple dosing, three treatment, three period, t...
Show More Location
Clinical Trials Center, Seoul National University Hospital
Learn More & Join Trial
A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes PHASE4 The process of atherosclerosis is multifactorial and involves many mechanis...
Show More Location
Hospital Clínico San Carlos
Learn More & Join Trial
Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes PHASE2 The objective of the study is to test the efficacy, safety and tolerability...
Show More Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211) PHASE3 This two-phase study was to examine if 16 weeks of treatment with sitaglipt...
Show More Location
Multiple Locations
Learn More & Join Trial
Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers PHASE1 This is a an open-label, randomized, single dose, four-way crossover, multi...
Show More Location
GSK Investigational Site
Treatments Being Tested
Metformin, 500 mg extended release tablet Metformin, 1000 mg extended release tablet Glimepiride, 1 mg immediate release tablet Glimepiride, 2 mg immediate release tablet Metformin, 500 mg and Glimepiride, 1 mg extended release film coated tablet containing release controlling polymers Metformin, 1000 mg and Glimepiride, 2 mg extended release film coated tablet containing release controlling polymers Metformin, 500 mg and Glimepiride, 1 mg extended release tablet coated with release controlling polymers Metformin, 1000 mg and Glimepiride, 2 mg extended release tablet coated with release controlling polymers Learn More & Join Trial
COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects. PHASE1 The purpose of this study is to assess, after single oral administration un...
Show More Location
Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit
Learn More & Join Trial
Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan PHASE4 Every lunar year, during the month of Ramadan, Muslims abstain from food an...
Show More Location
Jordan University Hospital
Learn More & Join Trial
Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients PHASE3 Primary Objective:
\- To demonstrate the superiority of glimepiride and me...
Show More Location
Investigational Site Number 01206
Learn More & Join Trial